NCT05431101 abSorbable vErsus Non-absorbable SuturEs for Wound Closure in Carpal Tunnel Release
| NCT ID | NCT05431101 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gelre Hospitals |
| Condition | Carpal Tunnel Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,604 participants |
| Start Date | 2022-05-01 |
| Primary Completion | 2028-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,604 participants in total. It began in 2022-05-01 with a primary completion date of 2028-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Carpal Tunnel Syndrome is a prevalent condition, up to 9% in women and 0.6% in men. Surgical decompression in the most effective treatment. After surgery, approximately 1,8% of the patients develop a wound infection. Possibly, the type of sutures used can influence the prevalence of wound infection. In this RCT the incidence of infection is investigated between the use of absorbable versus non-absorbable sutures in carpal tunnel release.
Eligibility Criteria
Inclusion Criteria: • indication for carpal tunnel release Exclusion Criteria: * carpal tunnel syndrome which has yet been operated * injection with corticosteroids
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05431101 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Carpal Tunnel Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05431101 currently recruiting?
Yes, NCT05431101 is actively recruiting participants. Contact the research team at paulineverhaegen@hotmail.com for enrollment information.
Where is the NCT05431101 trial being conducted?
This trial is being conducted at Apeldoorn, Netherlands, Deventer, Netherlands.
Who is sponsoring the NCT05431101 clinical trial?
NCT05431101 is sponsored by Gelre Hospitals. The trial plans to enroll 2,604 participants.